Clinical Trial Detail

NCT ID NCT03571321
Title Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors University of Chicago
Indications

acute lymphocytic leukemia

Therapies

Pegaspargase

Methotrexate

Cytarabine

Mercaptopurine

Thioguanine

Ruxolitinib

Cyclophosphamide

Dexamethasone

Vincristine

Rituximab

Doxorubicin

Age Groups: adult

Additional content available in CKB BOOST